Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene

Clinical Endocrinology

Volumn 59, Issue 4, 2003, Pages 511-518

  Elias, Paula C L ^a   Elias, Lucila L K ^a   Torres, Natalia ^a   Moreira, Ayrton C ^a   Antunes Rodrigues, Jose ^a   Castro, Margaret ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VASOPRESSIN;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; DISEASE COURSE; DNA DETERMINATION; DNA EXTRACTION; EVALUATION; FAMILIAL AUTOSOMAL DOMINANT NEUROHYPOPHYSEAL DIABETES INSIPIDUS; FAMILIAL DISEASE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; MALE; NEUROHYPOPHYSIS DISEASE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VASOPRESSIN RELEASE;

ADULT; CHILD; DIABETES INSIPIDUS, NEUROGENIC; EXONS; FEMALE; HUMANS; MALE; NEUROPHYSINS; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; VASOPRESSINS;

EID: 0141728373     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01834.x     Document Type: Article

References (58)

1. Abbes, A.P., Bruggeman, B., van Den Akker, E.L., de Groot, M.R., Franken, A.A., Drexhage, V.R. & Engel, H. (2000) Identification of two distinct mutations at the same nucleotide position, concomitantly with a novel polymorphism in the vasopressin-neurophysin II gene (AVP-NP II) in two Dutch families with familial neurohypophyseal diabetes insipidus. Clinical Chemistry, 46, 1699-1702.
2. Bahnsen, U., Oosting, P., Swaab, D.F., Nahke, P., Richter, D. & Schmale, H. (1992) A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus. Embo Journal, 11, 19-23.
3. Baylis, EH. (1998) Diabetes insipidus. Journal of Royal College Physicians London, 32, 108-111.
4. Baylis, P.H. & Robertson, G.L. (1981) Vasopressin function in familial cranial diabetes insipidus. Postgraduate Medical Journal, 57, 36-40.
5. Beuret, N., Rutishauser, J., Bider, M.D. & Spiess, M. (1999) Mechanism of endoplasmic reticulum retention of mutant vasopressin precursor caused by a signal peptide truncation associated with diabetes insipidus. Journal of Biology Chemistry, 274, 18965-18972.
6. Bullmann, C., Kotzka, J., Grimm, T., Heppner, C., Jockenhovel, F., Krone, W. & Muller-Wieland, D. (2002) Identification of a novel mutation in the arginine vasopressin-neurophysin II gene in familial central diabetes insipidus. Experimental and Clinical Endocrinology and Diabetes, 110, 134-137.
7. Calvo, B., Bilbao, J.R., Urrutia, I., Eizaguirre, J., Gaztambide, S. & Castano, L. (1998) Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 83, 995-997.
8. Calvo, B., Bilbao, J.R., Rodriguez, A., Rodriguez-Arnao, M.D. & Castano, L. (1999) Molecular analysis in familial neurohypophyseal diabetes insipidus: early diagnosis of an asymptomatic carrier. Journal of Clinical Endocrinology and Metabolism, 84, 3351-3354.
9. Chen, L.Q., Rose, J.P., Breslow, E., Yang, D., Chang, W.R., Furey, W.F. Jr, Sax, M. & Wang, B.C. (1991) Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 A determined from the single-wavelength anomalous scattering signal of an incorporated iodine atom. Procceedings of the National Academy of Sciences of the USA, 88, 4240-4244.
10. DiMeglio, L.A., Gagliardi, P.C., Browning, J.E., Quigley, C.A. & Repaske, D.R. (2001) A missense mutation encoding cys (67) → gly in neurophysin II is associated with early onset autosomal dominant neurohypophyseal diabetes insipidus. Molecular Genetics and Metabolism, 72, 39-44.
11. Elias, L.L., Antunes-Rodrigues, J., Elias, P.C. & Moreira, A.C. (1997) Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 82, 1243-1247.
12. Fluck, C.E., Deladoey, J., Nayak, S., Zeller, O., Kopp, P. & Mullis, P.E. (2001) Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II). European Journal of Endocrinology, 145, 439-444.
13. Fujii, H., Iida, S. & Moriwaki, K. (2000) Familial neurohypophyseal diabetes insipidus associated with a novel mutation in the vasopressin-neurophysin II gene. International Journal of Molecular Medicine, 5, 229-234.
14. Gagliardi, P.C., Bernasconi, S. & Repaske, D.R. (1997) Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23 → Val in neurophysin II. Journal of Clinical Endocrinology and Metabolism, 82, 3643-3646.
15. Goking, N.Q., Chertow, B.S., Robertson, G.L., Rittig, S., Siggaard, C. & Pedersen, E.B. (1997) Familial neurohypophyseal diabetes insipidus. A novel mutation presenting with enuresis. Journal of Investigative Medicine, 44, 29A.
16. Grant, F.D., Ahmadi, A., Hosley, C.M. & Majzoub, J.A. (1998) Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant. Journal of Clinical Endocrinology and Metabolism, 83, 3958-3964.
17. Green, J.R., Buchan, G.C., Alvord, E.C. Jr & Swanson, A.G. (1967) Heredtary and idiopathic types of diabetes insipidus. Brain, 90, 707-714.
18. Hansen, L.K., Rittig, S. & Robertson, G.L. (1997) Genetic basis of familial neurohypophyseal diabetes insipidus. Trends in Endocrionology and Metabolism, 8, 363-372.
19. Hendy, G.N. & Bichet, D.G. (1995) Diabetes insipidus. Baillieres Clinical Endocrinology and Metabolism, 9, 509-524.
20. Heppner, C., Kotzka, J., Bullmann, C., Krone, W. & Muller-Wieland, D. (1998) Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 83, 693-696.
21. Ito, M. & Jameson, J.L. (1997) Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. Journal of Clinical Investigation, 99, 1897-1905.
22. Ito, M., Oiso, Y., Murase, T., Kondo, K., Saito, H., Chinzei, T., Racchi, M. & Lively, M.O. (1993) Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus. Journal of Clinical Investigation, 91, 2565-2571.
23. Ito, M., Yu, R.N. & Jameson, J.L. (1999) Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. Journal of Biology Chemistry, 274, 9029-9037.
24. Iwasaki, Y., Oiso, Y., Saito, H. & Majzoub, J.A. (2000) Effects of various mutations in the neurophysin/glycopeptide portion of the vasopressin gene on vasopressin expression in vitro. Tohoku Journal of Experimental Medicine, 191, 187-202.
25. Kaplowitz, P.B., D'Ercole, A.J. & Robertson, G.L. (1982) Radioimmunoassay of vasopressin in familial cental diabetes insipidus. Journal of Pediatrics, 100, 76-81.
26. Kawakami, A., Okamoto, Y., Yamamoto, T., Tatsumi, Y., Miki, T., Tanaka, S. & Fujii, S. (1998) Central diabetes insipidus associated with a missense mutation in the arginine vasopressin gene that replaces Ala at the carboxyterminus of the signal peptide with Thr. International Medicine, 37, 683-686.
27. Krishnamani, M.R., Phillips, J.A., 3rd & Copeland, K.C. (1993) Detection of a novel arginine vasopressin defect by dideoxy fingerprinting. Journal of Clinical Endocrinology and Metabolism, 77, 596-598.
28. Kubota, T., Yamamoto, T., Ozono, K. & Shimotsuji, T. (2001) Hyperintensity of posterior pituitary on MR TIWI in a boy with central diabetes insipidus caused by missense mutation of neurophysin II gene. Endocrine Journ, 48, 459-463.
29. Land, H., Schutz, G., Schmale, H. & Richter, D. (1982) Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor. Nature, 295, 299-303.
30. Leal, A.M., Elias, P.C. & Moreira, A.C. (2002) Impairment of AVP regulation in 17α-hydroxylase deficiency, a unique form of adrenal insufficiency. Journal of Endocrinological Investigation, 25, 635-638.
31. McLeod, J.F., Kovacs, L., Gaskill, M.B., Rittig, S., Bradley, G.S. & Robertson, G.L. (1993) Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation. Journal of Clinical Endocrinology and Metabolism, 77, 599A-599G.
32. Mahoney, C.P., Weinberger, E., Bryant, C., Ito, M. & Jameson, J.L. (2002) Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the DeltaE47 neurophysin mutation. Journal of Clinical Endocrinology and Metabolism, 87, 870-876.
33. Meier, C.A. (1996) Molecular pathology of familial central diabetes insipidus. European Journal of Endocrinology, 134, 683-684.
34. Miller, M., Dalakos, T., Moses, A.M., Fellerman, H. & Streeten, D.H. (1970) Recognition of partial defects in antidiuretic hormone secretion. Annals of International Medicine, 73, 721-729.
35. Mundschenk, J., Rittig, S., Siggaard, C., Hensen, J. & Lehnert, H. (2001) A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus. Experimental and Clinical Endocrinology and Diabetes, 109, 406-409.
36. Nagasaki, H., Ito, M., Yuasa, H., Saito, H., Fukase, M., Hamada, K., Ishikawa, E., Katakami, H. & Oiso, Y. (1995) Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 80, 1352-1356.
37. Nijenhuis, M., van den Akker, E.L., Zalm, R., Franken, A.A., Abbes, A.P., Engel, H., de Wied, D. & Burbach, J.P (2001) Familial neurohypophysial diabetes insipidus in a large Dutch kindred: effect of the onset of diabetes on growth in children and cell biological defects of the mutant vasopressin prohormone. Journal of Clinical Endocrinology and Metabolism, 86, 3410-3420.
38. Nijenhuis, M., Zalm, R. & Burbach, J.P. (1999) Mutations in the vasopressin prohormone involved in diabetes insipidus impair endoplasmic reticulum export but not sorting. Journal of Biology Chemistry, 274, 21200-21208.
39. Nijenhuis, M., Zalm, R. & Burbach, J.P. (2000) A diabetes insipidus vasopressin prohormone altered outside the central core of neurophysin accumulates in the endoplasmic reticulum. Molecular Cell Endocrinology, 167, 55-67.
40. Olias, G., Richter, D. & Schmale, H. (1996) Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: defective transport of a mutant protein from patients with familial diabetes insipidus. DNA and Cell Biology, 15, 929-935.
41. Pedersen, E.B., Lamm, L.U., Albertsen, K., Madsen, M., Bruun-Petersen, G., Henningsen, K., Friedrich, U. & Magnusson, K. (1985) Familial cranial diabetes insipidus: a report of five families. Genetic, diagnostic and therapeutic aspects. Quaterly Journal of Medicine, 57, 883-896.
42. Rauch, F., Lenzner, C., Numberg, P., Frommel, C. & Vetter, U. (1996) A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Clinical Endocrinology, 44, 45-51.
43. Repaske, D.R. & Browning, J.E. (1994) A de novo mutation in the coding sequence for neurophysin-II (Pro24 → Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 79, 421-427.
44. Repaske, D.R., Summar, M.L., Krishnamani, M.R., Gultekin, E.K., Arriazu, M.C., Roubicek, M.E., Blanco, M., Isaac, G.B. & Phillips IIIrd, J.A. (1996) Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 81, 2328-2334.
45. Repaske, D.R., Medlej, R., Gultekin, E.K., Krishnamani, M.R., Halaby, G., Findling, J.W., Phillips, J.A. & 3rd (1997) Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1 → Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor. Journal of Clinical Endocrinology and Metabolism, 82, 51-56.
46. Riddell, D.C., Mallonee, R., Phillips, J.A., Parks, J.S., Sexton, L.A. & Hamerton, J.L. (1985) Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor. Somatic Cell and Molecular Genetics, 11, 189-195.
47. Rittig, S., Robertson, G.L., Siggaard, C., Kovacs, L., Gregersen, N., Nyborg, J. & Pedersen, E.B. (1996) Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. American Journal of Human Genetics, 58, 107-117.
48. Rittig, S., Siggaard, C., Ozata, M., Yetkin, I., Gregersen, N., Pedersen, E.B. & Robertson, G.L. (2002) Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine (2) in the vasopressin moiety of the hormone precursor. Journal of Clinical Endocrinology and Metabolism, 87, 3351-3355.
49. Robinson, A.G. & Verbalis, J.G. (1994) Diabetes insipidus. Current Therapy in Endocrinology and Metabolism, 5, 1-6.
50. Rutishauser, J., Boni-Schnetzler, M., Boni, J., Wichmann, W., Huisman, T., Vallotton, M.B. & Froesch, E.R. (1996) A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: co-segregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 81, 192-198.
51. Rutishauser, J., Kopp, P., Gaskill, M.B., Kotlar, T.J. & Robertson, G.L. (1999) A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus. Molecular Genetics and Metabolism, 67, 89-92.
52. Rutishauser, J., Kopp, P., Gaskill, M.B., Kotlar, T.J. & Robertson, G.L. (2002) Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene. European Journal of Endocrinology, 146, 649-656.
53. Santiprabhob, J., Browning, J. & Repaske, D. (2002) A missense mutation encoding Cys73Phe in neurophysin II is associated with autosomal dominant neurohypophyseal diabetes insipidus. Molecular Genetics and Metabolism, 77, 112.
54. Skordis, N., Patsalis, P.C., Hettinger, J.A., Kontou, M., Herakleous, E., Krishnamani, M.R. & Phillips IIIrd, J.A. (2000) A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes. Hormone Research, 53, 239-245.
55. Ueta, Y., Taniguchi, S., Yoshida, A., Murakami, I., Mitani, Y., Hisatome, I., Manabe, I., Sato, R., Tsuboi, M., Ohtahara, A., Nanba, E. & Shigemasa, C. (1996) A new type of familial central diabetes insipidus caused by a single-base substitution in the neurophysin II coding region of the vasopressin gene. Journal of Clinical Endocrinology and Metabolism, 81, 1787-1790.
56. Willcutts, M.D., Felner, E. & White, P.C. (1999) Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Human Molecular Genetics, 8, 1303-1307.
57. Yuasa, H., Ito, M., Nagasaki, H., Oiso, Y., Miyamoto, S., Sasaki, N. & Saito, H. (1993) Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus. Journal of Clinical Endocrinology and Metabolism, 77, 600-604.
58. Zerbe, R.L. & Robertson, G.L. (1981) A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. New England Journal of Medicine, 305, 1539-1546.